Federal
Register Notices > Importers
>
Cambrex Charles City, Inc.,
FR Doc E7-25055 [Federal Register: December 27, 2007 (Volume 72, Number
247)] [Notices] [Page 73357] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27de07-70]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing
a registration under this section to a bulk manufacturer of a controlled
substance in schedule I or II and prior to issuing a regulation under 21
U.S.C. 952(a)(2)(B) authorizing the importation of such a substance,
provide manufacturers holding registrations for the bulk manufacture of the
substance an opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal Regulations (CFR),
1301.34(a), this is notice that on November 22, 2007, Cambrex Charles City,
Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as an importer
of Phenylacetone (8501), a basic class of controlled substance listed in
schedule II.
The company plans to import Phenylacetone for use as a precursor in the
manufacture of amphetamines only.
Any bulk manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic class of controlled substance may file
comments or objections to the issuance of the proposed registration and may,
at the same time, file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), Washington, DC
20537, or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 28, 2008.
This procedure is to be conducted simultaneously with and independent of
the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the Federal Register on September 23, 1975,
(40 FR 43745-46), all applicants for registration to import a basic class of
any controlled substance listed in schedule I or II are, and will continue to
be, required to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21
U.S.C. 958(a), 21
U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-25055 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|